Europe — EMA
Paclitaxel Seacross
Paclitaxel, the active ingredient in Paclitaxel Seacross, is a mitotic inhibitor presented as a sterile powder for intravenous infusion use.
Request sourcing
1
Pack/s
What is Paclitaxel?
Paclitaxel, the active ingredient in Paclitaxel Seacross, is a mitotic inhibitor presented as a sterile powder for intravenous infusion use. It treats various malignant neoplasms and is administered in oncology settings.
GNH USA supplies Paclitaxel Seacross as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Paclitaxel used for?
Paclitaxel is a chemotherapy chemotherapy ... - ... ... ...
Product details
Drug
Paclitaxel
Route
Intravenous Use
Manufacturer
Seacross Pharma (Europe) Ltd
Origin
EU
Related products

Paclitaxel 100 mg/20mL
Paclitaxel · 100 mg/20 mL
Paclitaxel
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Teva Pharmaceuticals, Inc.
USA

PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100 mg/20mL
Paclitaxel · 100 mg/20 mL
Paclitaxel Protein Bound Particles Albumin Bound
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
American Regent, Inc.
USA

Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL
Paclitaxel
INJECTION, SOLUTION, CONCENTRATE
Teva Parenteral Medicines, Inc.
USA

Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL
Paclitaxel
INJECTION, SOLUTION, CONCENTRATE
Teva Parenteral Medicines, Inc.
USA